Impact of metastatic pattern and histologic subtype on PD-(L)1 inhibitor efficacy in HER2-negative advanced gastric and gastroesophageal cancer: a meta-analysis - Top-Institutions - MDSpire

Impact of metastatic pattern and histologic subtype on PD-(L)1 inhibitor efficacy in HER2-negative advanced gastric and gastroesophageal cancer: a meta-analysis

  • By

  • Derek Tai

  • Kyung-il Kim

  • Pranati Shah

  • Daniel Park

  • Lucas Kim

  • Jianan Li

  • Claire Jung

  • Sofia Guzman

  • Gagandeep Brar

  • Shengyang Wu

  • Dani Castillo

  • June 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    National University Hospital of Singapore
    National University Hospital of Singapore

    Singapore, SG

    Key Differentiators

    • Oncology

  • #3

    The Cancer Institute Hospital of Japanese Foundation for Cancer Research
    The Cancer Institute Hospital of Japanese Foundation for Cancer Research

    Tokyo, JP

    Key Differentiators

    • Oncology

Original Source(s)

Impact of metastatic pattern and histologic subtype on PD-(L)1 inhibitor efficacy in HER2-negative advanced gastric and gastroesophageal cancer: a meta-analysis

  • by Derek Tai, Kyung-il Kim, Pranati Shah, Daniel Park, Lucas Kim, Jianan Li, Claire Jung, Sofia Guzman, Gagandeep Brar, Shengyang Wu, Dani Castillo

  • June 29, 2026

Related Content

Pre-treatment CEMRI habitat radiomics and deep learning for noninvasive prediction of the VETC pattern in hepatocellular carcinoma: an exploratory radiogenomic analysis

High FCRL5 expression predicts poor treatment response and survival in newly diagnosed multiple myeloma: a retrospective study

Development of the glioma imaging complexity score (GICS): a volumetric MRI-based stratification framework